Skip to content
Catalyst

Matricaria chamomillaFinding

Matricaria chamomilla decreases systolic blood pressure (setting unspecified)

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“The chamomile group also had significantly lower mean arterial blood pressure (P = 0.0063; Fig. 5) and systolic pressure (P = 0.0012), and had a non-significant trend toward lower diastolic pressure (P = 0.057).”
Quoted verbatim from Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.
This finding among the 97 findings on its endpoint

Matricaria chamomilla

Systolic blood pressure (setting unspecified)

lowers

Who
adults with moderate-to-severe generalized anxiety disorder who responded to 12 weeks of open-label chamomile extract, then randomized to continue chamomile or switch to placebo for 26 weeks
Dose studied
1500 mg/day dry extract (500 mg capsule three times daily)

Moderate evidencePMID 27912875 · 2016

02 · The study

Study
RCT
Duration
6 months

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7FX2PAHBDVEY60T0XJVXVMN